Negative Regulation of Vascular Endothelial Growth Factor Receptor-2-Mediated Angiogenesis by Phosphatidylinositol 3-Kinase
/ 0
- Details
- Category: Vol. 82, June 2014
- Hits: 604
Negative Regulation of Vascular Endothelial Growth Factor Receptor-2-Mediated Angiogenesis by Phosphatidylinositol 3-Kinase, BAHJAT AL-ANI
Abstract
Objective: To test the hypothesis that vascular endothelial growth factor receptor-2 (VEGFR-2)-induced angiogenesis via phospholipase Cy (PLCy) may be negatively regulated by phosphatidylinositol 3-kinase (PI3K).
Design: Experimental cell lines study.
Setting: School of Experimental Medicine, College of Medicine and Dentistry, University of Birmingham, Birming-ham, UK.
Method: In vitro angiogenesis was assessed in porcine aortic endothelial cells stably expressing human VEGFR-2 (PAEC-hVEGFR-2) using pharmacological and molecular biology tools. In addition, endothelial cell lysates were im-munoblotted to assess the levels of active PLCy.
Result: Incubation of PAEC-hVEGFR-2 cells with the growth factor VEGF caused a partial capillary-like tube network formation in endothelial cells plated on growth-factor reduced Matrigel that was abrogated with U73122, a PLCy inhibitor. Preincubation of these endothelial cells with the PI3K inhibitor, LY294002 augmented VEGF-induced PLCy phosphorylation and capillary network. In addition, adenoviral gene transfer of the endogenous inhibitor of PI3K cell signal-ling, phosphatase and tensin homolog (PTEN) into PAEC-hVEGFR-2 caused a profound increase in VEGF-induced angiogenesis similar to the effect of the pharmacological inhibitor LY294002 that was not observed in the control group.
Conclusion: We conclude that inhibition of PI3K signif-icantly augmented VEGFR-2 induced angiogenesis, possibly due to a competition between PI3K and PLCy enzymes on the same shared substrate.